These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32637948)

  • 1. Genetic architecture of host proteins interacting with SARS-CoV-2.
    Pietzner M; Wheeler E; Carrasco-Zanini J; Raffler J; Kerrison ND; Oerton E; Auyeung VPW; Luan J; Finan C; Casas JP; Ostroff R; Williams SA; Kastenmüller G; Ralser M; Gamazon ER; Wareham NJ; Hingorani AD; Langenberg C
    bioRxiv; 2020 Jul; ():. PubMed ID: 32637948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic architecture of host proteins involved in SARS-CoV-2 infection.
    Pietzner M; Wheeler E; Carrasco-Zanini J; Raffler J; Kerrison ND; Oerton E; Auyeung VPW; Luan J; Finan C; Casas JP; Ostroff R; Williams SA; Kastenmüller G; Ralser M; Gamazon ER; Wareham NJ; Hingorani AD; Langenberg C
    Nat Commun; 2020 Dec; 11(1):6397. PubMed ID: 33328453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors.
    Kumawat A; Namsani S; Pramanik D; Roy S; Singh JK
    J Biomol Struct Dyn; 2022; 40(20):9897-9908. PubMed ID: 34155961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Policard M; Jain S; Rego S; Dakshanamurthy S
    Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
    Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
    BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
    Vela JM
    Front Pharmacol; 2020; 11():582310. PubMed ID: 33364957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Policard M; Jain S; Rego S; Dakshanamurthy S
    bioRxiv; 2021 Mar; ():. PubMed ID: 33619493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 metabolism: Mechanisms and therapeutic targets.
    Wang T; Cao Y; Zhang H; Wang Z; Man CH; Yang Y; Chen L; Xu S; Yan X; Zheng Q; Wang YP
    MedComm (2020); 2022 Sep; 3(3):e157. PubMed ID: 35958432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    Gordon DE; Jang GM; Bouhaddou M; Xu J; Obernier K; White KM; O'Meara MJ; Rezelj VV; Guo JZ; Swaney DL; Tummino TA; Hüttenhain R; Kaake RM; Richards AL; Tutuncuoglu B; Foussard H; Batra J; Haas K; Modak M; Kim M; Haas P; Polacco BJ; Braberg H; Fabius JM; Eckhardt M; Soucheray M; Bennett MJ; Cakir M; McGregor MJ; Li Q; Meyer B; Roesch F; Vallet T; Mac Kain A; Miorin L; Moreno E; Naing ZZC; Zhou Y; Peng S; Shi Y; Zhang Z; Shen W; Kirby IT; Melnyk JE; Chorba JS; Lou K; Dai SA; Barrio-Hernandez I; Memon D; Hernandez-Armenta C; Lyu J; Mathy CJP; Perica T; Pilla KB; Ganesan SJ; Saltzberg DJ; Rakesh R; Liu X; Rosenthal SB; Calviello L; Venkataramanan S; Liboy-Lugo J; Lin Y; Huang XP; Liu Y; Wankowicz SA; Bohn M; Safari M; Ugur FS; Koh C; Savar NS; Tran QD; Shengjuler D; Fletcher SJ; O'Neal MC; Cai Y; Chang JCJ; Broadhurst DJ; Klippsten S; Sharp PP; Wenzell NA; Kuzuoglu-Ozturk D; Wang HY; Trenker R; Young JM; Cavero DA; Hiatt J; Roth TL; Rathore U; Subramanian A; Noack J; Hubert M; Stroud RM; Frankel AD; Rosenberg OS; Verba KA; Agard DA; Ott M; Emerman M; Jura N; von Zastrow M; Verdin E; Ashworth A; Schwartz O; d'Enfert C; Mukherjee S; Jacobson M; Malik HS; Fujimori DG; Ideker T; Craik CS; Floor SN; Fraser JS; Gross JD; Sali A; Roth BL; Ruggero D; Taunton J; Kortemme T; Beltrao P; Vignuzzi M; García-Sastre A; Shokat KM; Shoichet BK; Krogan NJ
    Nature; 2020 Jul; 583(7816):459-468. PubMed ID: 32353859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteomic associations with genetics and health in the UK Biobank.
    Sun BB; Chiou J; Traylor M; Benner C; Hsu YH; Richardson TG; Surendran P; Mahajan A; Robins C; Vasquez-Grinnell SG; Hou L; Kvikstad EM; Burren OS; Davitte J; Ferber KL; Gillies CE; Hedman ÅK; Hu S; Lin T; Mikkilineni R; Pendergrass RK; Pickering C; Prins B; Baird D; Chen CY; Ward LD; Deaton AM; Welsh S; Willis CM; Lehner N; Arnold M; Wörheide MA; Suhre K; Kastenmüller G; Sethi A; Cule M; Raj A; ; ; ; ; ; ; ; ; ; Burkitt-Gray L; Melamud E; Black MH; Fauman EB; Howson JMM; Kang HM; McCarthy MI; Nioi P; Petrovski S; Scott RA; Smith EN; Szalma S; Waterworth DM; Mitnaul LJ; Szustakowski JD; Gibson BW; Miller MR; Whelan CD
    Nature; 2023 Oct; 622(7982):329-338. PubMed ID: 37794186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing.
    Maria NI; Rapicavoli RV; Alaimo S; Bischof E; Stasuzzo A; Broek JAC; Pulvirenti A; Mishra B; Duits AJ; Ferro A;
    Heliyon; 2023 Mar; 9(3):e14115. PubMed ID: 36911878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.